tailieunhanh - A cisplatin conjugate with tumor cell specificity exhibits antitumor effects in renal cancer models

Clear cell renal cell carcinoma (ccRCC) is the most common type of kidney cancer and is notorious for its resistance to both chemotherapy and small-molecule inhibitor targeted therapies. Subcellular targeted cancer therapy may thwart the resistance to produce a substantial effect. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN